Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Payables: 2022-2024

Historic Payables for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $2.3 million.

  • Gossamer Bio's Payables fell 63.49% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year decrease of 28.94%. This contributed to the annual value of $2.3 million for FY2024, which is 58.03% down from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Payables is $2.3 million, which was down 58.03% from $5.5 million recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Payables peaked at $5.5 million during FY2023, and registered a low of $1.5 million during FY2022.
  • Its 3-year average for Payables is $3.1 million, with a median of $2.3 million in 2024.
  • In the last 5 years, Gossamer Bio's Payables skyrocketed by 278.75% in 2023 and then plummeted by 58.03% in 2024.
  • Yearly analysis of 3 years shows Gossamer Bio's Payables stood at $1.5 million in 2022, then spiked by 278.75% to $5.5 million in 2023, then plummeted by 58.03% to $2.3 million in 2024.